1/260
Vaccination
can generate lifelong immunological memory
specific antibodies continue to be made for as long as 75 years after the last exposure to the vaccinia virus
many vaccinated individuals also retain populations of vaccinia-specific CD4 T cells and CD8 T cells
is a process of introducing a harmless form or component of a pathogen to stimulate the body's immune response. This leads to the production of antibodies and memory cells, enabling long-term protection against future infections
secondary immune response
The ability of the immune system to remember and respond more effectively to pathogens it has previously encountered, providing long-lasting protection.
memory responses are generally
faster, stronger and longer responses
eliminates pathogens before it can cause disease
circulating antibody, with long-lived specific B and T cells
antibodies can last several months
close cooperation b/w innate and adaptive immunity from start of infection
specific antibodies are already present
effector T cells are present and activated in the infected tissue
Immunological memory
low steady state level of antibodies that allow immune response to happen faster
this second immune response to the pathogen was mediated by high-affinity pathogen-specific IgG, memory T cells and memory B cells
Memory Cells compared to Naive Lymphocytes are
more sensitive to detection of infection
easier to activate because they require no signals
more abundant for their specific pathogens
What does the primary immune response produce?
Effector B cells
effector T cells
memory B cells
memory T cells
More effector than memory cells are produced, only a small amount of them actually become memory cells
Pathogen-specific memory B cells
more abundant and make better antibodies than naive B cells
more sensitive to specific antigen and therefore can response more quickly
make higher affinity antibody and higher affinity of antigen receptor (B cell receptor)
higher levels of MHC Class II and co-stimulatory molecules
get antibodies faster, in 4 days instead of 8 days
Cells of Immunological Memory
long-lived plasma cells that can individually live years to decades
they are unique because they are fully differentiated and do not need a clone to replicate
Memory T cells can live for decades. All T cells are clones that replace themselves by proliferation
Memory B cells can live for decades
How do B cells participate in the secondary immune response. What kinds of B cells participate?
only memory B cells participate in the secondary immune response
IgG suppresses activation of naive B cells by crosslinkgin the B cell receptor and the inhibitory Fc receptor
In early stage of primary immune response, pathogen binding to antigen receptor of naive B cell signals it to activate to become a plasma cell.
during later stages, the B cell receptor and inhibitory Fc receptor FcγRIIB1 on a naive B cell can be cross-linked by a pathogen coated with IgG. This delivers a signal that prevents the naive B cells from being activated.
Since memory B cells activated in a secondary response do not express FcγRIIB1, they are able to produce antibodies.
TLDR: If a pathogen in your system is already coated with IgG, that means antibodies are already being secreted to target this pathogen. Therefore, when the pathogen comes into the vicinity, it is already being coated with IgG. When a naive B cell tries to bind to it and activate, the Fc receptor of the IgG will bind to FcγRIIB1, inactivating the naive B cell. Naive B cell will not be able to activate. The memory B Cell does not have the FcγRIIB1 receptor, so it will bind the pathogen and secrete more high-affinity IgG.
How can vaccination induce a primary immune response?
the first encounter of a pathogen can be done through vaccinations
this means that when you actually encounter the pathogen, your immune response will have already been introduced to this pathogen because you got vaccinated
RhD+/- antigens,
up to 16% of individuals lack the erythrocyte antigen Rhesus D (RhD)
in the US, 85% of people are RhD positive, 15% are RhD negative
RhD is a surface protein antigen, and RBCs in your body are either RhD+ or - in each person
when an RhD- mother marries an RhD+ father, the mother carries an RhD+ fetus in her first pregnancy, this induces a primary immune response because the RhD- mother has never seen the RhD+ antigens
there are minor destruction of fetal erythrocytes by anti-RhD IgG. This is only minor because it’s a primary immune response
however, if the mother has subsequent pregnancies, a secondary immune response will be activated, which will lead to mass destruction of fetal erythrocytes triggered by anti-RhD IgGs
complement-mediated hemolysis of fetal erythrocytes results in a lack of sufficient cells for proper oxygenation of the fetus
Passive immunization with anti-RhD antigen IgG
to ensure newborn babies aren’t born anemic with Hemolytic Disease of the Newborn (HDN), mothers can be passively infuse with purified human anti-RhD antibodies during their first and subsequent pregnancies
anti-RhD antibodies coat the fetal erythrocytes with IgG to prevent the mother from making a primary B-cell response against the RhD antigen
this is similar to how new naive B cells are not activated in a secondary immune response because an abundant amount of antibodies already exist for that specific antigen
drug used is called WinRho SDF, also known as the Winnipeg-born Rh-factor antibody treatment
Transition of short-lived plasma cells to long-lived plasma cells
responding to infection, a large wave of short-lived plasma cells is
followed by a smaller, selected group of long-lived plasma cells
short-lived plasma cells last for weeks, long-lived plasma cells last for decades that persist in specialized niches
Escaping Immunological Memory
an example is Influenza
highly mutable virus that has multiple epitopes
influenza mutates rapidly, which is why a new vaccine is needed every year
in the first year, influenza could cause a primary antibody response to the epitopes A, B, C, and D. but as time passes, this strain could get mutated to A, B, C, and E. this makes the antibodies specified for ABCD weaker, until the strain gets fully mutated into a new strand such as EGFH. This EGFH strain would then require a whole new primary response
Antigenic Drift
Antigenic variation in Influenza due to accumulation of point mutations
Antigen activation of Naive CD8 T cells and generation of Memory T cells
On activation, naive CD8 T cells:
Becomes metabolically reprogrammed
Can undergo asymmetric division to give one daughter cell that is an Effector T cell (TE) and one that is a Memory T cell (TM)
Process: Naive CD8 T cell is activated by specific antigen, is then reprogrammed and enters mitosis. However undergoing mitosis, it also undergoes asymmetric division. This leads to one effector T cell and one memory T cell
Different Isoforms of CD45
make memory T cells easier to activate than naive T cells
Naive T cells make CD45RA
memory T cells make CD45RO
CD45RA is bigger than CD45RO and less able to interact with the T-cell receptor complex and activate T cells
therefore memory T cells express an isoform that associates better with the T cell receptor complex
CD45
transmembrane tyrosine phosphatase involved in T cell activation
through differential mRNA splicing, CD45 can be made into two isoforms, CD45RA and CD45RO
Cell-Surface Phenotypes
CD44: for cell adhesion, present in naive, effector and memory T cells, but more commonly effector and memory
CD45RO: tyrosine phosphatase present in all 3 but more commonly effector and memory
CD45RA: tyrosine phosphatase present in all 3 but more commonly naive
IFN-gamma: cytokine present in effector and memory T Cells
CD25: IL-2 receptor present in effector T cells
CD127: IL-7 receptor present in naive and memory T cells
Memory T cells and their patterns of Migration
central memory T cells circulate between blood, lymph and secondary lymphoid tissues
effector memory T cells circulate from blood to non-lymphoid tissues and then return in the lymph to the blood
resident memory T cells are based in non-lymphoid tissues where they can rapidly respond to local infections
Memory B cells
do not require co-stimulation through CD28
undergo further
somatic hypermutation
affinity maturation
isotype switching
more immunization = increase in amount and affinity of antibodies
Modern Vaccinology
Edward Jenner used vaccination with cowpox to protect people against smallpox
Cowpox also elicits T-cell immunity that cross-reacts with smallpox
Vaccine
preparation of the causative agent in a form that is capable of inducing immunity but unable to cause disease
stimulation adaptive immune response that will protect against future infection
Two Key elements of Adaptive Immunity
Specificity and Memory
Seroprotective threshold
immune response level necessary for protection
Factors that influence the immune response to vaccination
age (babies only have maternal antibodies, elderly have weakened immune system)
immunodeficiency
genetic factors (MHC)
nutritional state
storage conditions of vaccines
dose and administration route
any underlying illnesses
vaccine expiration
Herd Immunity
proportion of people immune to an infection is sufficiently high that transmission of the infection to susceptible individuals is greatly reduced
helps to protect those who are susceptible and cannot be immunized
i.e. Live vaccines for pregnant women and immunocompromised patients
Impact of Misinformation on vaccines
link between the MMR vaccine and autism was falsely alleged
number of children vaccinated decreased
outbreaks of measles increased in both frequency and size
Measles Complications - Subacute Sclerosing Panencephalitis (SSPE)
brain disease that is a late consequence of measles infection in some individuals
progressive neurological disorder characterized by inflammation of the brain
may develop due to reactivation of the measles virus or an inappropriate immune response to the measles virus
develops 2 to 10 years after the original viral attack
initial symptoms may include memory loss, irritability, seizures, involuntary muscle movements, and behavioral changes, leading to neurological deterioration
Success in Vaccination
Dramatic reduction in death and suffering from vaccine-preventable diseases
Dramatic decline in the incidence of diseases in countries with high vaccination coverage
The eradication of smallpox
Reduction in healthcare costs due to disease prevention
Reduction in cost to society (workdays lost)
Live Attenuated Viral Vaccines
Attenuated
virus that cannot cause the disease, but still possesses antigenic properties and can induce a protective immune response
prepared by repeated subculture or serial passage in various animal hosts
Mimics natural infection
multiplies in the individual
stimulation of both humoral and cellular immune responses
risk of reversion to virulence
How are attenuated viruses selected for?
growing human viruses in non-human cells
virus is first grown in quantity in human tissue culture cell. it is then isolated and grown in a non-human species (i.e. monkey) until it adapts fully to the non-human cell
a consequence of this is growing poorly in the human cell, therefore, this attenuated virus is present in amounts that can stimulate an immune response, but is usually not enough to cause a disease
examples of live attenuated viruses are MMR, chickenpox and rotavirus
Smallpox Eradication
smallpox was able to be eradicated because
no animal reservoir known
lifelong immunity upon vaccination/infection
subclinical cases were very rare
infectivity low before symptoms appear
only one single serotype
Concerns about Live Viral Vaccines
reversion to virulence since it is composed of live attenuated viral mutants
excretion of the live vaccine by the immunized person to infect others
contamination of the vaccine with a second virus during attenuated virus production
SV40 Simian Virus 40
Some polio vaccines used in the late 1950s and early 1960s were contaminated with called simian virus 40
present in monkey kidney cells used to grow the vaccine
SV40 was present in cancers of people who either had or had not received the polio vaccines that were contaminated with SV40
Killed Viral Vaccines
Contain purified killed virions in sufficiently high concentrations to induce immunity
Advantages:
cannot revert to virulence
more heat stable
can be safely given to immunodeficient patients and pregnant women
Disadvantages
needs several doses for full immunity
shorter duration of protection and is less protective in general
induces a weaker mucosal sIgA antibody response
Examples: Hepatitis A, Influenza, Rabies, Polio
Subunit Viral Vaccines
Contains the immunity-inducing component of the virion
Proteins purified from virus particles
Recombinant proteins
No reversion possible
Less immunogenic by itself
Example: Hepatitis B, Shingles Vaccine, HPV vaccine, recombinant influenza vaccine
Recombinant Vaccines
Produced by viral or bacterial strains that have been genetically engineered to express the genes of pathogens
advantages
purified combinant protein does not contain viral nucleic acid, cannot revert to virulence
no contaminating viruses
easily produced in large amounts and inexpensive
Hepatitis B Virus Vaccine
Consist of Hepatitis B surface Antigen (HBsAg)
First vaccine preparations were made from the blood of infected people
Now - recombinant HBsAg (Engerix-B)
gives 85% immunity
non-responders are usually people whose HLA Class II allotypes fail to present the HbsAg derived peptides
Polio Vaccines
Sabin attenuated vaccine
Attenuated by passage in foreign host (kidney cells from African green monkeys)
Selection to grow in new host made virus less suited to original host
Grows in epithelial cells (small intestine)
Does not grow in nerve ganglia
No paralysis
Local mucosal immunity (sIgA)
Salk killed polio vaccine
Weaker immunogen that does not induce mucosal immunity but protects against paralysis.
safer than sabin attenuated
Now, people take the inactivated vaccine over the oral vaccine because polio is less common
Properties of Viral Vaccines
Live-Attenuated
longer duration of immunity
greater effectiveness of protection
sIgA and IgG produced
possible reversion to virulence
low room temperature stability
possible virus excretion and transmission to non-immune contacts
Killed
shorter duration of immunity
less protective
iGG produced
no reversion to virulence
high room temperature stability
no virus excretion and transmission to non-immune contacts
Bacterial Vaccine Immunogens
Polysaccharide Capsule
Antibodies binding to the bacterial capsule neutralize the antiphagocytic effect of the capsule
Adherence pili
Antibodies to pili block adherence of bacteria to cells
Examples of Bacterial Vaccines: DTaP
Toxoids
Non-toxic, immunogenic preparations of toxins
Heat or chemically treated
Immunization with toxoid is efficacious for 1 year
Booster immunizations may be needed
Addition of adjuvants enhances immunogenicity
Adjuvants are molecules that are added to vaccines to enhance their immunogenicity.
DTaP
Combination Vaccine against Diphtheria, Tetanus, and Pertussis
Diphtheria: Toxoid of Corynebacterium diphtheriae
Tetanus: Toxoid of Clostridium tetani
Pertussis: Acellular Bordetella pertussis preparation
Immune response to diphtheria and tetanus toxoids is enhanced by acellular pertussis, which produces an inflammatory reaction at the site of injection
Vaccines Against Bacteria with Capsular Polysaccharides
Many pathogenic bacteria have an outer polysaccharide capsule
Subunit vaccines made of purified bacterial capsular polysaccharides can be effective in adults
children <18 months old and the elderly do not make good immune responses to capsular polysaccharides
children do not develop robust T-independent responses to polysaccharide antigens until a few years after birth
Solution: covalently link the polysaccharide to a carrier protein → Conjugate Vaccines
Haemophilus influenzae type B vaccine (HiB)
protects against meningitis in children
subunit vaccine
prepared from polysaccharide capsule of H. influenzae type B
to make this suitable for children under 18 months and the elderly, tetanus toxoid serves as a carrier protein, and provides antigenic peptides for stimulating a CD4+ T cell response
Conjugate vaccine
T cells responding to the protein carrier can stimulate HiB polysaccharide-specific B cells to make antibodies
Macromolecular complexes
recognized by both B and T cells make effective vaccines
naive B cell Ig binds carbohydrate epitope on a vaccine composed of polysaccharide conjugated to a tetanus toxoid, a protein. when the B cell degrades the vaccine conjugate, it can deliver the toxoid derived peptide to the TFH cell, which will help the T cell secrete cytokines that activate the B cell to differentiate into plasma cells
Streptococcus pneumoniae
Causes pneumonia
2 Capsular polysaccharides vaccines approved by FDA
Pneumococcal conjugate vaccine
recommended for infants and children
Pneumococcal polysaccharide vaccine
Meningococcal Vaccines
Meningitis is an infection that affects the delicate membranes (called meninges) that cover the brain and spinal cord
Disease is caused by a type of bacteria called Neisseria meningitidis
teenagers should get vaccinated for meningococcal disease
preteens should receive one dose of the serogroups of the bacteria A, C, W and Y
teens and young adults should receive a booster shot
they should also be vaccinated with serogroup B meningococcal vaccine
Meningitis Statistics
Approximately 1,000 people contract meningococcal disease in the U.S. each year
of those who get meningococcal disease, 15 percent die
Among those who survive, 20% live with permanent disabilities,
1 in 5 U.S. teens have not yet received their first dose of the meningococcal vaccination against serogroups A, C, W and Y and remain unprotected
Bacille Calmette-Guérin (BCG) Vaccine
Live attenuated strain of Mycobacterium bovis (bovine strain of Mycobacterium
Vaccine against tuberculosis (TB) since 1921
No longer used in the US because it invalidates TB skin test
Simple test that verifies exposure to Mycobacterium tuberculosis, gives a false positive
BCG is given by intradermal injection to reduce the risk of neurovascular injury
very difficult to administer
Rotavirus and Results from Vaccination
India went from 99000 deaths in 2008 → 10000 deaths in 2016 after 13% of their residents got vaccinated
India went from 28000 deaths in 2008 → 3000 deaths in 2016 after 80% of their residents got vaccinated
Angola went from 9000 deaths in 2008 → 2000 deaths in 2016 after 58% of their residents got vaccinated
Two effective Rotavirus Vaccines
Rotarix vaccine is an attenuated human rotavirus with VP7 G1 and VP4 P8 glycoproteins variants
RotaTeq vaccine is based on a cattle rotavirus that is nonpathogenic to humans. consists of five viral strains
four of the strains express differenr human VP7 glycoprotein variants
one expresses cattle VP7 and human P8 variant of VP4
Adjuvants
Enhance the Immune response (non-specific)
modern adjuvants are TLR agonists
Vaccination with Neisseria factor H–binding protein (fHbp)
Neisseria uses fHbp to prevent complement fixation on its surface
fHbp is a surface lipoprotein that binds factor H and uses it to inactivate any C3b deposited on the bacterial surface
Factor I is used to cleave C3b into iC3b
prevents formation of the membrane attack complex and lysis of Neisseria
Vaccination generates high-affinity IgG antibodies against fHbp that cover up its binding site for factor H and:
prevents its interference with the complement activation by the alternative pathway
coating the bacteria with anti-fHbp IgG also activates classical pathway
Diarrheal disease
leading disease in global annual mortality
about 1.7 billion people are estimated to have been previously or currently infected
Post-Exposure to Hepatitis C virus
Less than 30% of people defeat the virus
More than 70% develop chronic infection
RNA Vaccines
based on mRNA inside a lipid membrane
fatty cover both protects mRNA when it first enters the body and helps it get to inside cells by fusing with cell membrane
effective but not long-lasting
when inside cell, machinery inside cell translates it into antigen protein
only lasts a few days but is sufficient to stimulate an immune response
naturally broken down and removed by the body. they are not capable of combining with the human genetic code (DNA)
Angiotensin-converting enzyme 2, or ACE2
Protein that provides the entry point for the coronavirus
break down angiotensin II into molecules that counteract angiotensin II’s harmful effects; but if the virus occupies the ACE2 ‘receptor’ on the surface of cells, then its role is blunted
Drugs called ACE inhibitors inhibit the formation of angiotensin II
Dengue (DEN4CYD) vaccine
Live attenuated tetravalent chimeric vaccine made using recombinant DNA technology by replacing the PrM (pre-membrane) and E (envelope) structural genes of yellow fever attenuated 17D strain vaccine with those from the four dengue serotypes.
Indicated for ages 9-16 years, with evidence of prior infection, who live in endemic areas (Puerto Rico, American Samoa, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of Marshall Islands, and the Republic of Palau).
Pathogen
an agent that can cause disease in healthy individuals
opportunistic pathogen
an agent that causes disease only when host defenses are weak
obligatory steps for pathogens
Attachment and entry into host cell
Multiplication
Local or systemic spread in the body
Evasion of host defense mechanisms
Transmission
Stages of Infection
Infectious microorganism enters through epithelial tissues
infectious agent must first adhere to the epithelial cells and then cross the epithelium
local innate immune response may prevent an infection from being established
If not, innate response will::
help contain the infection
delivers infectious agent to local lymph nodes
initiate the adaptive response for eventual clearance of the infection
Survival Strategies of Pathogens
rapid replication
evasion of host response
inducing a minimal response
antigenic variation
suppression of host response
Macrophages
Found in healthy tissues
Variety of mature forms
Slightly increased levels during inflammation
Long-lived, survive after phagocytosis of pathogen
Neutrophils
Found only in inflamed tissues
Single mature form
Rapid increase in numbers during acute phase response
Short-lived, die after phagocytosis of pathogen
Genetic variation
within some species of pathogens that prevents humans from having long-term immunity
example: Streptococcus pneumoniae causes bacterial pneumonia, otitis media, meningitis
different strains, or serotypes of S. pneumoniae have antigenically different capsular polysaccharides
Antibodies against capsular polysaccharides bind to the pathogen to facilitate phagocytosis
A person infected with one serotype of S. pneumoniae clears the infection with type-specific antibody.
antibodies have no protective effect when the same person is infected with a different serotype of S. pneumoniae
therefore, the second infection can only be cleared by a new primary response
Genetic Variation using Streptococcus pneumoniae as an Example
Strains (serotypes) of S. pneumoniae have antigenically different capsular polysaccharides
antibodies against capsular polysaccharides opsonize the pathogen, causing phagocytosis
a person infected with S. pneumoniae can clear the infection with a type-specific antibody, but that same antibody won’t be able to protect that person from a subsequent infection with a different S. pneumoniae serotype
Influenza
RNA virus whose genome has 8 RNA segments
causes rapidly spreading, short-lived epidemics of respiratory tract infections
causes a worldwide pandemic every 10-50 yers
master of antigenic variation
Antigenic Drift
Antigenic variation due to accumulation of point mutations
example: in influenza, an individual infected with strain V produces antibodies against the viral hemagglutinin. in their secondary response, they will have antibodies that can bind to these hemagglutinin. However, point mutations within the hemagglutinin gene of strain V that originate in infections elsewhere eliminate the epitopes recognized by the protective antibodies. This allows the variant virus, strain V*, to successfully re-infect the individual immune to strain V.
Antigenic Shift
resulting from the reassortment of gene segments between two different strains that co-infect the same host cell
example: human influenza virus and an avian influenza virus simultaneously infect a cell within the secondary host, a pig, and their RNA segments become reassorted to produce a reassortant virus. this reassortant virus expresses hemagglutinin of avian origin which is different from the original human virus, which can now go infect humans who do not have an immune response to it yet.
Reassortment
form of genetic recombination that occurs in RNA viruses with segmented genomes
Trypanosomes
use gene rearrangements to change surface antigens
Trypanosoma brucei
african trypanosomiasis
causes sleeping sickness
insect bites transmits protozoa
multiply in the extracellular space b/w cell
surface proteins are encoded by >1000 genes
(Variable Surface Glycoproteins, VSG)
Causes progresive central nervous system (CNS) pathology involving meninges, choroid, blood brain barrier, immunopathological changes including perivascular infiltrations and alternations in the cytokine network
Variable Surface Glycoproteins (VSG)
Found on Trypanosomes
More than 1000 genes
many inactive trypanosome VSG genes but only one site for expression
once VSG-specific antibody is made, the other is expressed VSG gene is replaced by another VSG gene though gene oconversion
Successive rounds of gene conversion and expression of new VSG gene allow the parasite to flourish
causes a cycle in which parasite populations (red, yellow, and
blue lines) alternate between high and low numbers
analogy: think of it like a vinyl and a record player, you can only play one vinyl at once, similarly you can only express one VSG gene at once

American Trypanosomiasis (Chagas Disease)
Trypanosoma cruzi does not have VSGs
hides from the immune system by living within host cells
taken up by phagocytosis and escapes from the lysozyme into the cytoplasm with the help of special protein that is activated at low pH
parasites divide intracellularly in infected muscle cells
Most people living with Chagas disease are unaware of their diagnosis, often until it’s too late :(
In California, has up to 100K people infected, it is a neglected tropical disease
spreads through an insect knwon as the “kissing bug”, with the most common being the Triatoma protracta
Herpesviruses
persist in human hosts by hiding from the immune response
Herpes simplex viruses cause:
cold sores (HSV-1)
genital herpes (HSV-2)
Varicella-zoster virus → chickenpox and shingles
epstein-barr virus → mononucleosis and cancer
Cytomegalovirus → birth defects and diseases in immunosuppressed patients
Herpesviruses cause:
acute infection
reactivated infections
recurrent herpes
shingles
certain cancers
How can the Immune Response be Blocked?
Human Cytomegalovirus (HCMV)
interferes with MHC Class I function in many ways
Multiple simultaneous strategies
10 different proteins produced by CMV to block immune response, need to learn the following four:
US2: transports HLA class I to cytoplasm for degradation by proteasome
US3: retains HLA Class I in the endoplasmic reticulum by blocking tapasin function
UL83: Blocks access to the proteasome and the generation of MHC class I binding peptides
UL142: downregulates the expression of the MIC-A and MIC-B ligands of NKG2D
NKG2D is a receptor on NK cells and ɣδT cells that mediates the killing of MIC-expressing infected or cancer cells
Human Herpesviruses and Target Cells
Target cell for infection:
mucosal epithelial cells, B cells, monocytes, T cells and lympocytes are good target cells for infection
Target cell for latency:
neurons, B cells, monocytes, T cells
How does HSV (Herpes Simplex Virus) stay Persistent?
Immune response clears initial infection around the lips, leaves tissue damage to manifest as cold sores
in the meantime, the virus enters sensory neurons, i.e. those in the trigeminal ganglion whose axons innervate the lips, where it persists in latent state
various types of stress can cause virus to leave neurons and reinfect epithelium, then reactivates the immune response and causes cold sores.
people with HSV periodically get cold sores due to this process
transmission of the virus from one person to another is easier during this state
Bacterial Superantigens
bind α:β T cell receptors and MHC class II in a non-specific manner
causes massive but inappropriate “cytokine storm”
T cells are over-stimulated and produce high levels of proinflammatory cytokines such as IL-1, IL-2, IL-6 and TNF-alpha
can lead to septic shock, aka when immune system overreacts
Evasion of IgA-mediated defense by bacterial superantigen
combination of specific IgA and FcaR1 on phagocytes eliminates bacteria that breach a mucosal barrier and infect the underlying tissue
Staphylococcal Superantigen-Like Protein 7 (SSLP7) blocks this mechanism for disposing of bacteria
by binding both C5 and the Fc region of IgA, SSLP7:
prevents IgA from binding to the FcaR1 receptor on phagocytes, avoiding phagocytosis
Blocks the activation of complement-mediated killing of the bacteria by the membrane attack complex

Eight Functional Groups of Primary Immunodeficiency Syndrome
Immunodeficiencies affecting cellular and humoral immunity
Combined immunodeficiencies with associated or syndromic features
Predominantly antibody deficiencies
Diseases of immune dysregulation
Congenital defects of phagocyte number, function, or both
Defects in intrinsic and innate immunity
Autoinflammatory disorders
Complement deficiencies
All of these groups are major autosomal recessive alleles, with the exception of group 7 which are mainly Autosomal dominant alleles
X-Linked Agammaglobulinemia (XLA)
In XLA, B cells do not develop beyond the pre-B-cell stage, Bruton’s tyrosine kinase (BTK) is defective. Pre-B-cell receptor cannot generate intracellular signals, no light chain added
this leads to recurrent bacterial infections
males are more affected because they only have one X chromosome and there is no BTK gene on the smaller Y chromosome
heterozygous females are carriers of the trait but are themselves healthy
cells in all females randomly inactivate one X chromosome, leading to B cell development arrest if the female is a carrier for XLA and inactivates the normal X
Deficiencies in Pathways of Complement Activation
Immune complex diseases are inflammatory conditions characterized by antigen-antibody deposition and activation of complement
Remember these:
• Deficiency in C1, C2, and C4 causes immune complex diseases
• Deficiency in C3 causes susceptibility to encapsulated bacteria
• Deficiency in C5-C9 causes susceptibility to Neisseria
• Deficiency in DAF and CD59 causes autoimmune-like conditions including
paroxysmal nocturnal hemoglobinuria
• Deficiency in C1INH causes Hereditary Angioedema (HAE)
C1INH
inactivates C1r and C1s enzymes
is a protease inhibitor
acts as a pseudosubstrate
permanent covalent linkage to the protease
deficiency in C1INH causes hereditary angioedema
When you have an infection, you want to use complement and then you want to turn it off to not cause more damage. Hereditary angioedema is inflammation of the blood vessels with edema
Examples of Defects in Phagocytic Cells → Persistent Bacterial Infections
Chronic granulomatous disease, necessary for oxidative burst to kill bacteria that are engulfed. No respiratory burst means can’t kill pathogen
Chediak-higashi syndrome: defective phagocytosis, also with endosomes, can’t get lysosomes inside to kill pathogens
Granuloma
aggregation of macrophages that forms in response to chronic inflammation. This occurs when the immune system attempts to isolate foreign substances that it is otherwise unable to eliminate
Body is not able to eliminate the pathogen, this is a compromise. Going to trap bacteria in there and it might be able to replicate but it is not leaving the structure
Severe Combined Immune Deficiencies (SCID)
Several types:
X-Linked: mutation in gene coding for common gamma chain (ɣ) needed for several cytokine receptors (IL-2R, IL-4R)
Wiskott-Aldrich Syndrome: X-linked deficiency of T cell activation. Defect in the gene for a protein needed for cytoskeletal reorganization, poor antibody responses
Omenn Syndrome: RAG Defects, deficient VDJ gene segment recombination
no functional T or B cells
Adenosine Deaminase Deficiency: Defect in purine degradation. Nucleotide metabolites accumulate and are toxic to developing T and B cells
some children treated by gene therapy
Impairment of Intracellular bacterial infection responses
IL-12 receptor and IFN-γ receptor deficiency
these deficiencies affect both innate and adaptive immunity because you use IL-12, IL-12 activates neutrophils in innate immunity, in adaptive immunity, it activates effector T cells and macrophages in the adaptive immune response
Origins of HIV and AIDS
Chimpanzee; HIV-1
Sooty mangabey; HIV-2
Acquired Immunodeficiency Syndrome (AIDS)
Caused by: Human Immunodeficiency Virus (HIV)
Profound immunosuppression
opportunistic infections
malignancies
wasting
CNS degreation
HIV Receptor is CD4, meaning it targets CD4+ cells
Main Co-receptors for HIV are Chemokine Receptors:
CCR5
CXCR4
HIV Viral Structure
Lipid bilayer, 3 major enzymes, integrase, protease, reverse transcriptase
Has glycoproteins such as gp120 and gp41 that bind to T cell receptors, they also form the viral spike
HIV Receptor and Co-receptor
Interaction b/w GP120 and envelope glycoprotein with both the receptor CD4 and a chemokin co-receptor. HIV uses reverse transcriptase to make ssDNA from mRNA, which is then made into a dsDNA that can integrate into our genes
HIV-2 is not as deadly as HIV-1
disease caused by HIV-2 depends on the viral load
With a viral load of 100 or less the infection is controlled, and those infected survive for as long as the uninfected control population does
people with HIV-2 generally live longer/as long as normal people
HIV Infection Cycle
GP120 envelope protein of virus binds to CD4, which also enables it to bind the co-receptor
Binding releases GP41, causing fusion of viral envelope with plasma membrane and release of viral core into the cytoplasm
RNA genome is release and reverse transcribed into double stranded complementary DNA (cDNA)
DNA migrates to nucleus in association with viral integrate and becomes integrated into cell genome as a provirus
activation of T cell causes low level transcription of provirus into mRNA that directs synthesis of early proteins Tat and Rev
proteins change the pattern of provirus transcriptions to produce mRNA encoding protein constituents of the virion and RNA molecules corresponding to the HIV genome
envelope proteins travel to plasma membrane, and other viral proteins and viral genomic RNA assemble into nucleocapsids
new virus particles bud from the cell, acquiring their lipid envelope and envelope glycoproteins in the process
Effects on CD4 T cells due to HIV
gradual reduction of CD4 T Cells
opportunistic infections and other symptoms become more frequent as CD4 T Cell count starts falling (around 500 cells/µL). Humans normally have 1000 cells/µL, and around 200 cells/µL is when the patient is diagnosed as having AIDs
Effects of AIDs due to age
rate of progression to AIDS of HIV-infected people increases with age because capacity to generate new T cells decreases with age
Example: In order to treat hemophilia, blood from healthy donors was infused into the hemophiliac. However, in the early 1980s, some healthy blood donors contracted HIV, therefore leading to infections in recipients of the blood. Research showed that rate progression to AIDs of HIV infected people increases with age.
Now we have Recombinant Coagulation factors, a new way to treat hemophiliacs without the risk of contracting HIV
Natural Course of HIV Infection
early phase → adaptive immune response being activated so the virus reaches high levels
mid phase → production of HIV-specific antibodies and cytotoxic T cells, virus is controlled but not eliminated
later phase → destruction of CD4 T cells outstrips their renewal, adaptive immunity declines and levels of virus increase again
HIV and Protease Inhibitor Drugs
when patient is treated w/ one type of protease inhibitor drug, decrease in viral load and increase in CD4T-cells numbers are not permanent
drug selects for rare drug-resistant HIV variants that rapidly increase in number and continue the progression to AIDs
Anti-retroviral combination therapy
can reduce HIV to undetectable levels in the blood
virus remains in the lymphoid tissue
can increase the number of circulating CD4 T cells
infected cells only live for a few days once infected, and administering the anti-retroviral drug blocks the viral life cycle. Existing virions in the blood are rapidly cleared by the actions of neutralizing antibody, complement and phagocytes
therefore, newly produced CD4 T cells are uninfected, living longer and accumulating in circulation
essentially, this drug attempts to block some part of viral replication